medRxiv

medRxiv
Name	medRxiv
Type	Preprint server
Registration	Optional
Language	English
Owner	Cold Spring Harbor Laboratory, BMJ, Yale University
Launch date	2019
Current status	Active

medRxiv is a free online archive and distribution server for complete but unpublished manuscripts, known as preprints, in the medical science and related fields, operated by Cold Spring Harbor Laboratory, BMJ, and Yale University. The server was launched in 2019 to provide a platform for researchers to share their findings quickly and facilitate collaboration among scientists, including those from Harvard University, Stanford University, and University of Oxford. medRxiv is similar to other preprint servers, such as arXiv and bioRxiv, which are used by physicists, like Stephen Hawking and Neil deGrasse Tyson, and biologists, like James Watson and Francis Crick. medRxiv has been endorsed by prominent researchers, including Anthony Fauci, David Ho, and Eric Topol, from institutions like National Institutes of Health and World Health Organization.

Introduction

medRxiv is designed to accelerate the dissemination of new research findings in the medical sciences, including epidemiology, public health, and clinical trials, conducted by researchers from Johns Hopkins University, University of California, Los Angeles, and Columbia University. By providing a platform for researchers to share their work before it has been peer-reviewed, medRxiv aims to facilitate collaboration, accelerate discovery, and improve the quality of research, as seen in the work of Nobel laureates like Barbara McClintock and Rosalyn Yalow. medRxiv is also used by researchers from European Organization for Nuclear Research, National Academy of Sciences, and American Medical Association to share their findings on various topics, including cancer research, infectious diseases, and neuroscience, with the help of artificial intelligence and machine learning techniques developed by researchers from Massachusetts Institute of Technology and Carnegie Mellon University.

History

The concept of preprint servers dates back to the 1990s, when Paul Ginsparg launched arXiv for physicists, including Richard Feynman and Murray Gell-Mann, and mathematicians, like Andrew Wiles and Grigori Perelman. The success of arXiv led to the development of other preprint servers, including bioRxiv, which was launched in 2013 for biologists, such as Craig Venter and Jennifer Doudna, and chemists, like Linus Pauling and Marie Curie. medRxiv was launched in 2019 as a collaboration between Cold Spring Harbor Laboratory, BMJ, and Yale University, with the support of researchers from University of Cambridge, University of California, Berkeley, and Duke University. The server has been endorsed by prominent researchers, including Fauci, Ho, and Topol, from institutions like National Institutes of Health and World Health Organization.

Functionality

medRxiv allows researchers to submit their manuscripts, which are then screened for plagiarism and other forms of academic misconduct, using tools developed by researchers from Stanford University and Massachusetts Institute of Technology. The manuscripts are then posted on the server, where they can be accessed by anyone, including researchers from Harvard University, University of Oxford, and California Institute of Technology. medRxiv also provides a platform for researchers to comment on and discuss the manuscripts, facilitating collaboration and feedback, as seen in the work of researchers from European Molecular Biology Laboratory and National Center for Biotechnology Information. The server also provides DOIs for each manuscript, making it easier to cite and track the work, using citation tools developed by researchers from University of California, Los Angeles and Columbia University.

Impact

medRxiv has had a significant impact on the dissemination of medical research, particularly during the COVID-19 pandemic, when researchers from Johns Hopkins University, University of Washington, and University of California, San Francisco used the server to share their findings quickly. The server has been used by researchers from World Health Organization, Centers for Disease Control and Prevention, and National Institutes of Health to share their research on vaccines, treatments, and diagnostics, using data from European Centre for Disease Prevention and Control and Chinese Center for Disease Control and Prevention. medRxiv has also been used to share research on other topics, including cancer research, neuroscience, and infectious diseases, conducted by researchers from University of Cambridge, University of California, Berkeley, and Duke University. The server has been praised for its ability to accelerate the dissemination of research findings and facilitate collaboration among researchers, including those from American Medical Association and European Medical Association.

Criticisms_and_controversies

medRxiv has faced criticism for its lack of peer review, which some argue can lead to the dissemination of pseudoscience or misinformation, as seen in the cases of Andrew Wakefield and Stanton Glantz. However, proponents of medRxiv argue that the server provides a necessary platform for researchers to share their findings quickly, particularly during public health emergencies, like the SARS outbreak and Ebola outbreak, when researchers from World Health Organization and Centers for Disease Control and Prevention used the server to share their findings. medRxiv has also been criticized for its potential to perpetuate academic misconduct, such as plagiarism and data fabrication, which can be detected using tools developed by researchers from Stanford University and Massachusetts Institute of Technology. However, the server has implemented measures to screen for such misconduct, including the use of plagiarism detection software developed by researchers from University of California, Los Angeles and Columbia University.

Publications_and_statistics

medRxiv has published thousands of manuscripts since its launch, including research on COVID-19, cancer research, and neuroscience, conducted by researchers from Harvard University, University of Oxford, and California Institute of Technology. The server has been used by researchers from over 100 countries, including United States, China, and United Kingdom, and has been accessed by millions of users, including researchers from National Institutes of Health and World Health Organization. medRxiv has also been cited in numerous news outlets, including The New York Times, The Lancet, and Nature, and has been recognized as a valuable resource for researchers, clinicians, and policymakers, including those from American Medical Association and European Medical Association. The server's usage statistics are publicly available, providing insights into the dissemination of medical research, using data analysis techniques developed by researchers from Massachusetts Institute of Technology and Carnegie Mellon University.

Category:Medical research